Hemostatic risk factors in ischemic stroke

Thrombosis and Haemostasis

Volumn 90, Issue 6, 2003, Pages 1094-1099

  Biasiutti, Franziska Demarmels ^a   Berger, Daniela ^a   Mattle, Heinrich P ^a   Lämmle, Bernhard ^a   Wuillemin, Walter A ^a,b  

^a UNIVERSITY OF BERN   (Switzerland)

^b LUZERNER KANTONSSPITAL   (Switzerland)

Author keywords

Coagulation; Factor V; Ischemic stroke; Risk factors

Indexed keywords

BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 7; FIBRINOGEN; PROTHROMBIN;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BLOOD CLOTTING; BODY MASS; CASE CONTROL STUDY; CEREBROVASCULAR ACCIDENT; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; FEMALE; GENDER; HEMOSTASIS; HIGH RISK PATIENT; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PATHOGENESIS; PLASMA; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SMOKING HABIT; STATISTICAL ANALYSIS; SURVIVAL TIME; THROMBOPHILIA;

EID: 0347533975     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/th03-03-0134     Document Type: Article

References (36)

1. WHO. Report of the WHO Task Force on Stroke and other Cerebrovascular Disorders. Stroke-1989: Recommendations on stroke prevention, diagnosis, and therapy. Stroke 1989; 20: 1407-31.
2. Sacco RL, Benjamin EJ, Broderick JP, et al. AHA Conference Proceedings: Risk factors. Stroke 1997; 28: 1507-17.
3. Wolf PA. Prevention of stroke. Lancet 1998; suppl. III:15-18.
4. Shinton R, Beevers G. Meta-analysis of relation between smoking and stroke. Br Med J 1989; 25: 789-94.
5. Wannamethee SG, Perry IJ, Shaper G. Nonfasting serum glucose and insulin concentrations and the risk of stroke. Stroke 1999; 30: 1780-6.
6. Iso H, Jacobs DR Jr, Wentworth D, et al. Serum cholesterol levels and six-year mortality from stroke in 350'977 men screened for the multiple risk factor intervention trial. N Engl J Med 1989; 320: 904-10.
7. Tegos TJ, Kalodiki E, Daskalopoulou SS, et al. Stroke: Epidemiology, clinical picture, and risk factors. Angiology 2000;51: 793-808.
8. Catto AJ, Grant PJ. Risk factors for cerebrovascular disease and the role of coagulation and fibrinolysis. Blood Coagul Fibrinolysis 1995; 6: 497-510.
9. Wilhelmsen L, Svardsudd K, Korsan-Bengtsen K, et al. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 1984; 23: 501-5.
10. Kannel WB, Wolf PA, Castelli WP, et al. Fibrinogen and risk of cardiovascular disease: The Framingham Study. JAMA 1987; 258: 1183-6.
11. Ernst E, Resch KL. Fibrinogen as a cardiovascular risk factor: A meta-analysis and review of the literature. Ann Int Med 1993; 118: 956-63.
12. Kario K, Matsuo M, Miyata T. Are there any associations among coagulation factor VII gene polymorphism, plasma activated factor VII levels, and cerebrovascular disease? Circulation 2000; 101: E48.
13. Folsom AR, Rosamond WD, Shahar E, et al. for the ARIC Study investigators. Prospective study of markers of hemostatic function with risk of ischemic stroke. Circulation 1999; 100: 736-42.
14. Qizilbash N, Duffy S, Prentice CR, et al. Von Willebrand factor and risk of ischemic stroke. Neurology 1997; 49: 1552-56.
15. Smith FB, Lee AJ, Fowkes FGR, et al. Hemostatic factors as predictors of ischemic heart disease and stroke in the Edinburgh Artery Study. Arterioscler Thromb Vasc Biol 1997; 17: 3321-5.
16. Mackro RF, Kittner SJ, Epstein A, et al. Elevated tissue plasminogen activator antigen and stroke risk. The stroke prevention in young women study. Stroke 1999; 30: 7-11.
17. De Stefano V, Chiusolo P, Paciaroni K, et al. Prothrombin G20210A mutant genotype is a risk factor for cerebrovascular ischemic disease in young patients. Blood 1998; 91: 3562-5.
18. Ridker PM, Hennekens CH, Miletich JP. G20210A mutation in prothrombin gene and risk of myocardial infarction, stroke, and venous thrombosis in a large cohort of US men. Circulation 1999; 99: 999-1004.
19. Szolnoki Z, Somogyvári F, Szabó M, et al. A clustering of unfavourable common genetic mutations in stroke cases. Acta Neurol Scand 2000; 102: 124-8.
20. Wu AH, Tsongalis GJ. Correlation of polymorphisms to coagulation and biochemical risk factors for cardiovascular diseases. Am J Cardiol 2001; 87: 1361-6.
21. Catto A, Carter A, Ireland H, et al. Factor V Leiden gene mutation and thrombin generation in relation to the development of acute stroke. Arterioscler Thromb Vasc Biol 1995; 15: 783-5.
22. Ridker PM, Hennekens CH, Lindpaintner K, et al. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke and venous thrombosis in apparently healthy men. N Engl J Med 1995; 332: 912-7
23. Voetsch B, Damasceno BP, Camargo ECS, et al. Inherited thrombophilia as a risk factor for the development of ischemic stroke in young adults. Thromb Haemost 2000; 83: 229-33.
24. Sacco RL, Owen J, Mohr JP, et al. Free protein S deficiency: A possible association with cerebrovascular occlusion. Stroke 1989; 20: 1657-61.
25. D'Amico D, Moschiano F, Leone M, et al. Genetic abnormalities of the protein C system: Shared risk factors in young adults with migraine with aura and with ischemic stroke. Cephalgia 1998; 18: 618-21.
26. Boushey CJ, Beresford SA, Omenn GS, et al. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: Probable benefits of increasing folic acid intakes. JAMA 1995; 274: 1049-57.
27. Madonna P, De Stefano V, Coppola A, et al. Hyperhomocysteinemia and other inherited prothrombotic conditions in young adults with a history of ischemic stroke. Stroke 2002; 33: 51-56.
28. Vasse M, Guegan-Massardier E, Borg JY, et al. Frequency of protein Z deficiency in patients with ischemic stroke. Lancet 2001; 357: 933-4.
29. Kobelt K, Demarmels Biasiutti F, Mattle HP, et al. Protein Z in ischemic stroke. Br J Haematol 2001; 114: 169-73.
30. Tuhrim S, Rand JH, Wu X, et al. Antiphosphatidyl serine antibodies are independently associated with ischemic stroke. Neurology 1999; 53: 1523-7.
31. Brey RL, Hart RG, Sherman DG, et al. Antiphospholipid antibodies and cerebral ischemia in young people. Neurology 1990; 40: 1190-6.
32. Adams HP, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter trial. TOAST. Trial of ORG 10172 in acute stroke treatment. Stroke 1993; 24: 35-41.
33. Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol 1957; 17: 237-46.
34. Bland JM, Altman DG. Multiple significance tests: The Bonferroni method. Br Med J 1995; 310: 170.
35. Hankey GJ, Eikelboom JW, van Bockxmeer FM, et al. Inherited thrombophilia in ischemic stroke and its pathogenic subtypes. Stroke 2001; 32: 1793-9.
36. Redondo M, Watzke HH, Stucki B, et al. Coagulation factors II, V, VII, and X, prothrombin gene 20210G→A transition, and factor V Leiden in coronary artery disease. High factor V clotting activity is an independent risk factor for myocardial infarction. Arterioscler Thromb Vasc Biol 1999; 19: 1020-5.